OTCMKTS:OLYMY

Olympus (OLYMY) Stock Price, News & Analysis

$16.26
+0.41 (+2.59%)
(As of 05/17/2024 ET)
Today's Range
$16.22
$16.28
50-Day Range
$13.62
$16.29
52-Week Range
$11.91
$16.69
Volume
24,952 shs
Average Volume
54,638 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
OLYMY stock logo

About Olympus Stock (OTCMKTS:OLYMY)

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy systems, surgical microscopes, endoscope reprocessors, and maintenance services. The Therapeutic Solutions Business segment provides urology, gynecology, respiratory, ear, nose, and throat products; GI endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials, such as synthetic bone filler, and orthopedic equipment. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Tokyo, Japan.

OLYMY Stock Price History

OLYMY Stock News Headlines

How To Get Shadow In Hades 2
How to get to the Surface in Hades 2
See More Headlines
Receive OLYMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Olympus and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:OLYMY
CIK
N/A
Fax
N/A
Employees
32,844
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Yasuo Takeuchi (Age 67)
    Representative Executive Officer, ESG Officer & Executive Chairman
    Comp: $2.41M
  • Mr. Andre Roggan
    Executive Officer & CTO
  • Stephen Kneebone
    Corporate Officer & Chief Information Officer
  • Mr. Stefan Kaufmann (Age 56)
    Representative Executive Officer, President, CEO & Director
    Comp: $4.18M
  • Izumi Tatsuya (Age 60)
    Executive Officer & Chief Financial Officer
  • Takaaki Sakurai
    Vice President of Investor Relations
  • Ms. Donna Miller
    Head of HQ Legal and Global General Counsel
  • Shigeto Ohtsuki
    Executive Officer & Chief Human Resources Officer
  • Mr. Tetsuo Kobayashi
    Executive Officer and Chief Manufacturing & Supply Officer
  • Hidenao Tsuchiya
    Corporate Officer , Regional Representative Officer of China & Chairman, Olympus (China) Co., Ltd.

OLYMY Stock Analysis - Frequently Asked Questions

How have OLYMY shares performed in 2024?

Olympus' stock was trading at $14.3660 at the beginning of the year. Since then, OLYMY stock has increased by 13.2% and is now trading at $16.26.
View the best growth stocks for 2024 here
.

Are investors shorting Olympus?

Olympus saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 12,200 shares, a drop of 35.8% from the April 15th total of 19,000 shares. Based on an average daily volume of 117,400 shares, the days-to-cover ratio is presently 0.1 days.
View Olympus' Short Interest
.

How do I buy shares of Olympus?

Shares of OLYMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:OLYMY) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners